Comparison of Estradiol and Misoprostol in Transformation Zone Visibility in Colposcopy

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

MODARES GILANI MITRA; YARANDI FARIBA; ZAMANI NARGES; Norouzi Shaghayegh; Ramhormozian Sara; SHIRALI ELHAM

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: JOURNAL OF OBSTETRICS GYNECOLOGY AND CANCER RESEARCH Year:2022 | Volume:7 | Issue:2 Page(s): 77-82

Download Full-Text

View:

Download:

Cites:

Information Journal Paper

Title

Comparison of Estradiol and Misoprostol in Transformation Zone Visibility in Colposcopy

Author(s)

Keywords

Estradiol

Misoprostol

Colposcopy

Transformation Zone

Visibility

Abstract

Background & Objective: Estradiol and Misoprostol have been used for the enhancement of Transformation Zone (TZ) Visibility in vaginal Colposcopy. However, no consensus has been reached on the superiority of one medication over the other. This study aimed to compare the efficacy of Estradiol and Misoprostol for the enhancement of TZ Visibility in vaginal Colposcopy of premenopausal and postmenopausal women. Materials & Methods: In this clinical trial, 78 patients with unsatisfactory Colposcopy were randomly divided into three groups. Group 1 (n=25) received 25 µ, g of vaginal Estradiol for 14 days prior to Colposcopy. Group 2 (n=27) received 400 µ, g of Misoprostol 12 h prior to Colposcopy. Group 3 (n=26) served as the control group and did not receive any medication. Visibility of the TZ, age, body mass index (BMI), history of vaginal delivery, history of sexually transmitted diseases, history of human papillomavirus (HPV), the reason for Colposcopy, and drug-related side effects were compared among the three groups and also between premenopausal and postmenopausal women. Data were analyzed using analysis of variance (ANOVA), Kruskal-Wallis, Chi-square, and Fisher’, s exact tests. Results: The percentage of TZ Visibility was 72%, 55. 6%, and 26. 9% in the Estradiol, Misoprostol, and control groups, respectively (P=0. 005). These values were 70%, 33. 3%, and 0%, respectively, in postmenopausal women (P=0. 043) and 60%, 72. 7%, and 33. 3%, respectively, in premenopausal women (P=0. 152). Regarding drug-related side effects, there was no statistically significant difference between the three groups (P=0. 374). Conclusion: Estradiol was significantly superior to Misoprostol for the enhancement of TZ Visibility, particularly in postmenopausal women, with no difference regarding side effects.

Multimedia

No record.

Cites

No record.

References

No record.

Cite

APA: Copy

MODARES GILANI, MITRA, YARANDI, FARIBA, ZAMANI, NARGES, Norouzi, Shaghayegh, Ramhormozian, Sara, & SHIRALI, ELHAM. (2022). Comparison of Estradiol and Misoprostol in Transformation Zone Visibility in Colposcopy. JOURNAL OF OBSTETRICS GYNECOLOGY AND CANCER RESEARCH, 7(2), 77-82. SID. https://sid.ir/paper/1056850/en

Vancouver: Copy

MODARES GILANI MITRA, YARANDI FARIBA, ZAMANI NARGES, Norouzi Shaghayegh, Ramhormozian Sara, SHIRALI ELHAM. Comparison of Estradiol and Misoprostol in Transformation Zone Visibility in Colposcopy. JOURNAL OF OBSTETRICS GYNECOLOGY AND CANCER RESEARCH[Internet]. 2022;7(2):77-82. Available from: https://sid.ir/paper/1056850/en

IEEE: Copy

MITRA MODARES GILANI, FARIBA YARANDI, NARGES ZAMANI, Shaghayegh Norouzi, Sara Ramhormozian, and ELHAM SHIRALI, “Comparison of Estradiol and Misoprostol in Transformation Zone Visibility in Colposcopy,” JOURNAL OF OBSTETRICS GYNECOLOGY AND CANCER RESEARCH, vol. 7, no. 2, pp. 77–82, 2022, [Online]. Available: https://sid.ir/paper/1056850/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops